Flavoproteins are potential targets for the antibiotic roseoflavin in Escherichia coli

Journal of Bacteriology

Volumn 195, Issue 18, 2013, Pages 4037-4045

  Langer, Simone ^a   Hashimoto, Masayuki ^b   Hobl, Birgit ^a   Mathes, Tilo ^c   Mack, Matthias ^a  

^a MANNHEIM UNIVERSITY OF APPLIED SCIENCES   (Germany)

^b SHINSHU UNIVERSITY   (Japan)

^c HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; FLAVINE MONONUCLEOTIDE; FLAVOPROTEIN; RIBOFLAVIN DERIVATIVE; ROSEOFLAVIN; ROSEOFLAVIN ADENINE DINUCLEOTIDE; ROSEOFLAVIN MONONUCLEOTIDE; UNCLASSIFIED DRUG;

ARTICLE; CYTOPLASM; ESCHERICHIA COLI; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION;

ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; ESCHERICHIA COLI; FLAVIN-ADENINE DINUCLEOTIDE; FLAVOPROTEINS; NUCLEOTIDYLTRANSFERASES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECOMBINANT PROTEINS; RIBOFLAVIN;

EID: 84883306665     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00646-13     Document Type: Article

References (47)

1. Jankowitsch F, Schwarz J, Ruckert C, Gust B, Szczepanowski R, Blom J, Pelzer S, Kalinowski J, Mack M. 2012. Genome sequence of the bacterium Streptomyces davawensis JCM 4913 and heterologous production of the unique antibiotic roseoflavin. J. Bacteriol. 194:6818-6827.
2. Otani S, Takatsu M, Nakano M, Kasai S, Miura R. 1974. Letter: roseoflavin, a new antimicrobial pigment from Streptomyces. J. Antibiot. (Tokyo) 27:86-87.
3. Kasai S, Kubo Y, Yamanaka S, Hirota T, Sato H, Tsuzukida Y, Matusi K. 1978. Anti-riboflavin activity of 8N-alkyl analogues of roseoflavin in some Gram-positive bacteria. J. Nutr. Sci. Vitaminol. (Tokyo) 24:339-350.
4. Grill S, Yamaguchi H, Wagner H, Zwahlen L, Kusch U, Mack M. 2007. Identification and characterization of two Streptomyces davawensis riboflavin biosynthesis gene clusters. Arch. Microbiol. 188:377-387.
5. Hemberger S, Pedrolli DB, Stolz J, Vogl C, Lehmann M, Mack M. 2011. RibM from Streptomyces davawensis is a riboflavin/roseoflavin transporter and may be useful for the optimization of riboflavin production strains. BMC Biotechnol. 11:119-129.
6. Vogl C, Grill S, Schilling O, Stulke J, Mack M, Stolz J. 2007. Characterization of riboflavin (vitamin B2) transport proteins from Bacillus subtilis and Corynebacterium glutamicum. J. Bacteriol. 189:7367-7375.
7. Burgess CM, Slotboom DJ, Geertsma ER, Duurkens RH, Poolman B, van Sinderen D. 2006. The riboflavin transporter RibU in Lactococcus lactis: molecular characterization of gene expression and the transport mechanism. J. Bacteriol. 188:2752-2760.
8. Rodionov DA, Hebbeln P, Eudes A, ter Beek J, Rodionova IA, Erkens GB, Slotboom DJ, Gelfand MS, Osterman AL, Hanson AD, Eitinger T. 2009. A novel class of modular transporters for vitamins in prokaryotes. J. Bacteriol. 191:42-51.
9. Grill S, Busenbender S, Pfeiffer M, Kohler U, Mack M. 2008. The bifunctional flavokinase/flavin adenine dinucleotide synthetase from Streptomyces davawensis produces inactive flavin cofactors and is not involved in resistance to the antibiotic roseoflavin. J. Bacteriol. 190:1546-1553.
10. Pedrolli DB, Matern A, Wang J, Ester M, Siedler K, Breaker R, Mack M. 2012. A highly specialized flavin mononucleotide riboswitch responds differently to similar ligands and confers roseoflavin resistance to Streptomyces davawensis. Nucleic Acids Res. 40:8662-8673.
11. Mansjo M, Johansson J. 2011. The riboflavin analog roseoflavin targets an FMN-riboswitch and blocks Listeria monocytogenes growth, but also stimulates virulence gene-expression and infection.RNABiol. 8:674-680.
12. Lee ER, Blount KF, Breaker RR. 2009. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biol. 6:187-194.
13. Ott E, Stolz J, Lehmann M, Mack M. 2009. The RFN riboswitch of Bacillus subtilis is a target for the antibiotic roseoflavin produced by Streptomyces davawensis. RNA Biol. 6:276-280.
14. Winkler WC, Cohen-Chalamish S, Breaker RR. 2002. An mRNA structure that controls gene expression by binding FMN. Proc. Natl. Acad. Sci. U. S. A. 99:15908-15913.
15. Macheroux P, Kappes B, Ealick SE. 2011. Flavogenomics-a genomic and structural view of flavin-dependent proteins. FEBS J. 278:2625-2634.
16. Otani S, Matsui K, Kasai S. 1997. Chemistry and biochemistry of 8-aminoflavins. Osaka City Med. J. 43:107-137.
17. Yorita K, Misaki H, Palfey BA, Massey V. 2000. On the interpretation of quantitative structure-function activity relationship data for lactate oxidase. Proc. Natl. Acad. Sci. U. S. A. 97:2480-2485.
18. Langer S, Nakanishi S, Mathes T, Knaus T, Binter A, Macheroux P, Mase T, Miyakawa T, Tanokura M, Mack M. 2013. The flavoenzyme azobenzene reductase AzoR from Escherichia coli binds roseoflavin mono-nucleotide (RoFMN) with high affinity and is less active in its RoFMN form. Biochemistry 52:4288-4295.
19. Fischer M, Bacher A. 2005. Biosynthesis of flavocoenzymes. Nat. Prod. Rep. 22:324-350.
20. Kitagawa M, Ara T, Arifuzzaman M, Ioka-Nakamichi T, Inamoto E, Toyonaga H, Mori H. 2005. Complete set of ORF clones of Escherichia coli ASKA library (a complete set of E. coli K-12 ORF archive): unique resources for biological research. DNA Res. 12:291-299.
21. Pedrolli DB, Nakanishi S, Barile M, Mansurova M, Carmona EC, Lux A, Gartner W, Mack M. 2011. The antibiotics roseoflavin and 8-demethyl-8-amino-riboflavin from Streptomyces davawensis are metabolized by human flavokinase and human FAD synthetase. Biochem. Pharmacol. 82:1853-1859.
22. Saito H, Shibata T, Ando T. 1979. Mapping of genes determining nonpermissiveness and host-specific restriction to bacteriophages in Bacillus subtilis Marburg. Mol. Gen. Genet. 170:117-122.
23. Andrews JM. 2001. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48(Suppl 1):5-16.
24. Capo-chichi CD, Gueant JL, Feillet F, Namour F, Vidailhet M. 2000. Analysis of riboflavin and riboflavin cofactor levels in plasma by highperformance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 739:219-224.
25. Jankowitsch F, Kuhm C, Kellner R, Kalinowski J, Pelzer S, Macheroux P, Mack M. 2011. A novel N,N-8-amino-8-demethyl-D-riboflavin dimethyltransferase (RosA) catalyzing the two terminal steps of roseoflavin biosynthesis in Streptomyces davawensis. J. Biol. Chem. 286:38275-38285.
26. Mathes T, Vogl C, Stolz J, Hegemann P. 2009. In vivo generation of flavoproteins with modified cofactors. J. Mol. Biol. 385:1511-1518.
27. Keseler IM, Mackie A, Peralta-Gil M, Santos-Zavaleta A, Gama-Castro S, Bonavides-Martinez C, Fulcher C, Huerta AM, Kothari A, Krummenacker M, Latendresse M, Muniz-Rascado L, Ong Q, Paley S, Schroder I, Shearer AG, Subhraveti P, Travers M, Weerasinghe D, Weiss V, Collado-Vides J, Gunsalus RP, Paulsen I, Karp PD. 2013. EcoCyc: fusing model organism databases with systems biology. Nucleic Acids Res. 41: D605-612.
28. Plumbridge J. 1998. Control of the expression of the manXYZ operon in Escherichia coli: Mlc is a negative regulator of the mannose PTS. Mol. Microbiol. 27:369-380.
29. Gerdes SY, Scholle MD, D'Souza M, Bernal A, Baev MV, Farrell M, Kurnasov OV, Daugherty MD, Mseeh F, Polanuyer BM, Campbell JW, Anantha S, Shatalin KY, Chowdhury SA, Fonstein MY, Osterman AL. 2002. From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J. Bacteriol. 184:4555-4572.
30. Tokunaga M, Loranger JM, Chang SY, Regue M, Chang S, Wu HC. 1985. Identification of prolipoprotein signal peptidase and genomic organization of the lsp gene in Escherichia coli. J. Biol. Chem. 260:5610-5615.
31. Mata-Gilsinger M, Ritzenthaler P. 1983. Physical mapping of the exuT and uxaC operators by use of exu plasmids and generation of deletion mutants in vitro. J. Bacteriol. 155:973-982.
32. White PJ, Millar G, Coggins JR. 1988. The overexpression, purification and complete amino acid sequence of chorismate synthase from Escherichia coli K12 and its comparison with the enzyme from Neurospora crassa. Biochem. J. 251:313-322.
33. Eschenbrenner M, Coves J, Fontecave M. 1995. The flavin reductase activity of the flavoprotein component of sulfite reductase from Escherichia coli. A new model for the protein structure. J. Biol. Chem. 270: 20550-20555.
34. Liang X, Thorpe C, Schulz H. 2000. 2,4-Dienoyl-CoA reductase from Escherichia coli is a novel iron-sulfur flavoprotein that functions in fatty acid beta-oxidation. Arch. Biochem. Biophys. 380:373-379.
35. Zenno S, Koike H, Kumar AN, Jayaraman R, Tanokura M, Saigo K. 1996. Biochemical characterization of NfsA, the Escherichia coli major nitroreductase exhibiting a high amino acid sequence homology to Frp, a Vibrio harveyi flavin oxidoreductase. J. Bacteriol. 178:4508-4514.
36. Cunningham L, Guest JR. 1998. Transcription and transcript processing in the sdhCDAB-sucABCD operon of Escherichia coli. Microbiology 144: 2113-2123.
37. Hasford JJ, Rizzo CJ. 1998. Linear free energy substituent effect on flavin redox chemistry. J. Am. Chem. Soc. 120:2251-2255.
38. Yorita K, Janko K, Aki K, Ghisla S, Palfey BA, Massey V. 1997. On the reaction mechanism of L-lactate oxidase: quantitative structure-activity analysis of the reaction with para-substituted L-mandelates. Proc. Natl. Acad. Sci. U. S. A. 94:9590-9595.
39. Walsh C, Fisher J, Spencer R, Graham DW, Ashton WT, Brown JE, Brown RD, Rogers EF. 1978. Chemical and enzymatic properties of riboflavin analogues. Biochemistry 17:1942-1951.
40. Fraaije MW, Mattevi A. 2000. Flavoenzymes: diverse catalysts with recurrent features. Trends Biochem. Sci. 25:126-132.
41. Joosten V, van Berkel WJ. 2007. Flavoenzymes. Curr. Opin. Chem. Biol. 11:195-202.
42. Merrill AH, Jr, Kasai S, Matsui K, Tsuge H, McCormick DB. 1979. Spectroscopic studies of pyridoxamine (pyridoxine) 5=-phosphate oxidase. Equilibrium dissociation constants and spectra for riboflavin 5=-phosphate and analogues. Biochemistry 18:3635-3641.
43. Pedrolli DB, Jankowitsch F, Schwarz J, Langer S, Nakanishi S, Frei E, Mack M. 2013. Riboflavin analogs as antiinfectives: occurrence, mode of action, metabolism and resistance. Curr. Pharm. Des. 19:2552-2560.
44. Coquard D, Huecas M, Ott M, van Dijl JM, van Loon AP, Hohmann HP. 1997. Molecular cloning and characterisation of the ribC gene from Bacillus subtilis: a point mutation in ribC results in riboflavin overproduction. Mol. Gen. Genet. 254:81-84.
45. Mack M, van Loon AP, Hohmann HP. 1998. Regulation of riboflavin biosynthesis in Bacillus subtilis is affected by the activity of the flavokinase/ flavin adenine dinucleotide synthetase encoded by ribC. J. Bacteriol. 180: 950-955.
46. Kil YV, Mironov VN, Gorishin I, Kreneva RA, Perumov DA. 1992. Riboflavin operon of Bacillus subtilis: unusual symmetric arrangement of the regulatory region. Mol. Gen. Genet. 233:483-486.
47. Vitreschak AG, Rodionov DA, Mironov AA, Gelfand MS. 2002. Regulation of riboflavin biosynthesis and transport genes in bacteria by transcriptional and translational attenuation. Nucleic Acids Res. 30:3141-3151.